Pulmatrix Statistics
Total Valuation
Pulmatrix has a market cap or net worth of $7.30 million. The enterprise value is -$383,420.
| Market Cap | 7.30M |
| Enterprise Value | -383,420 |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 7.10% |
| Float | 3.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.59, with a Debt / Equity ratio of 0.45.
| Current Ratio | 5.59 |
| Quick Ratio | 5.37 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.10% and return on invested capital (ROIC) is -34.05%.
| Return on Equity (ROE) | -44.10% |
| Return on Assets (ROA) | -26.70% |
| Return on Capital (ROIC) | -34.05% |
| Revenue Per Employee | $531,091 |
| Profits Per Employee | -$402,182 |
| Employee Count | 22 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.86% in the last 52 weeks. The beta is 0.94, so Pulmatrix's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -28.86% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 53.60 |
| Average Volume (20 Days) | 6,391 |
Short Selling Information
The latest short interest is 499, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 499 |
| Short Previous Month | 2,183 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Pulmatrix had revenue of $11.68 million and -$8.85 million in losses. Loss per share was -$2.41.
| Revenue | 11.68M |
| Gross Profit | 11.68M |
| Operating Income | -9.41M |
| Pretax Income | -8.85M |
| Net Income | -8.85M |
| EBITDA | -7.50M |
| EBIT | -8.85M |
| Loss Per Share | -$2.41 |
Balance Sheet
The company has $16.30 million in cash and $8.61 million in debt, giving a net cash position of $7.69 million or $2.10 per share.
| Cash & Cash Equivalents | 16.30M |
| Total Debt | 8.61M |
| Net Cash | 7.69M |
| Net Cash Per Share | $2.10 |
| Equity (Book Value) | 19.02M |
| Book Value Per Share | 5.21 |
| Working Capital | 14.44M |
Cash Flow
In the last 12 months, operating cash flow was -$13.78 million and capital expenditures -$830,000, giving a free cash flow of -$14.61 million.
| Operating Cash Flow | -13.78M |
| Capital Expenditures | -830,000 |
| Free Cash Flow | -14.61M |
| FCF Per Share | -$4.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -80.52% and -75.73%.
| Gross Margin | 100.00% |
| Operating Margin | -80.52% |
| Pretax Margin | -75.73% |
| Profit Margin | -75.73% |
| EBITDA Margin | -64.19% |
| EBIT Margin | -75.73% |
| FCF Margin | -125.01% |
Dividends & Yields
Pulmatrix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -121.13% |
| FCF Yield | -199.96% |
Analyst Forecast
The average price target for Pulmatrix is $10.00, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 400.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 1, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
Pulmatrix has an Altman Z-Score of -12.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.83 |
| Piotroski F-Score | 1 |